The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock

Chinese Critical Care Medicine

Volumn 24, Issue 1, 2012, Pages 38-41

  Lü, Jie ^a   Zhao, Hui Ying ^a   Liu, Fang ^a   An, You Zhong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Coagulation; Fibrinolysis; Hydroxyethyl starch; Lactate Ringer solution; Septic shock

Indexed keywords

HETASTARCH; RINGER LACTATE SOLUTION; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CELL PROTECTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FIBRINOLYSIS; FLUID RESUSCITATION; HUMAN; HYPERCOAGULABILITY; INTENSIVE CARE UNIT; LENGTH OF STAY; OUTCOME ASSESSMENT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RISK REDUCTION; SEPTIC SHOCK; VASCULAR ENDOTHELIUM;

AGED; FEMALE; FLUID THERAPY; HETASTARCH; HUMANS; ISOTONIC SOLUTIONS; MALE; MIDDLE AGED; PARTIAL THROMBOPLASTIN TIME; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSPECTIVE STUDIES; RESUSCITATION; SHOCK, SEPTIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84863169551     PISSN: 10030603     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1003-0603.2012.01.009     Document Type: Article

References (13)

1. de Jonge E, Dekkers PE, Creasey AA, et al. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia. Blood,2000,95:1124-1129. (Pubitemid 30099814)
2. DePalo V, Kessler C, Opal SM. Success or failure in phase III sepsis trials: comparison between the drotrecogin alfa (activated) and antithrombin III clinical trials. Adv Sepsis,2001,1:114-124.
3. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med,2004,32:1825-1831. (Pubitemid 39202356)
4. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med,2008,34:17-60.
5. Inan N, Iltar S, Surer H, et al. Effect of hydroxyethyl starch 130/0.4 on ischaemia/reperfusion in rabbit skeletal muscle. Eur J Anaes thesiol,2009,26:160-165.
6. ] Esmon CT. The impact of the inflammatory response on coagulation. Thromb Res,2004,114:321-327. (Pubitemid 39422563)
7. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost,1997,78:974-983. (Pubitemid 27417285)
8. Petroianu GA, Liu J, Maleck WH, et al. The effect of in vitro hemodilution with gelatin, dextran, hydroxyethyl starch, or Ringer's solution on thrombelastogragh. Anesth Analg,2000,90:795-800. (Pubitemid 30190780)